Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 4Terminated 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 4Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Quality of Life 1Neoplasms 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Quality of Life × Breast × Clear all
NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Mansoura University

Phase 3 Unknown
116 enrolled
Breast

Breast Neoplasms

NCT05287139 2022-03-18

BRAVE

Beneficência Portuguesa de São Paulo

Unknown
202 enrolled
Breast

Quality of Life

NCT04834570 2021-04-08

Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment

Instituto Brasileiro de Controle do Cancer

Unknown
105 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT02261311 2016-09-16

RADSII

Ottawa Hospital Research Institute

Unknown
200 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡